These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 39205953)

  • 1. The Suggested Relationships Between Common GI Symptoms and Joint Hypermobility, POTS, and MCAS.
    Quigley EMM; Noble O; Ansari U
    Gastroenterol Hepatol (N Y); 2024 Aug; 20(8):479-489. PubMed ID: 39205953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS).
    Kucharik AH; Chang C
    Clin Rev Allergy Immunol; 2020 Jun; 58(3):273-297. PubMed ID: 31267471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional gastrointestinal disorders are increased in joint hypermobility-related disorders with concomitant postural orthostatic tachycardia syndrome.
    Tai FWD; Palsson OS; Lam CY; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
    Neurogastroenterol Motil; 2020 Dec; 32(12):e13975. PubMed ID: 32803794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms and management of gastrointestinal symptoms in postural orthostatic tachycardia syndrome.
    Tu Y; Abell TL; Raj SR; Mar PL
    Neurogastroenterol Motil; 2020 Dec; 32(12):e14031. PubMed ID: 33140561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysautonomia, Hypermobility Spectrum Disorders and Mast Cell Activation Syndrome as Migraine Comorbidities.
    Blitshteyn S
    Curr Neurol Neurosci Rep; 2023 Nov; 23(11):769-776. PubMed ID: 37847487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome.
    Miller AJ; Stiles LE; Sheehan T; Bascom R; Levy HP; Francomano CA; Arnold AC
    Auton Neurosci; 2020 Mar; 224():102637. PubMed ID: 31954224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long COVID and hypermobility spectrum disorders have shared pathophysiology.
    Ganesh R; Munipalli B
    Front Neurol; 2024; 15():1455498. PubMed ID: 39301475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and impact of orthostatic intolerance in young women across the hypermobility spectrum.
    Peebles KC; Tan I; Butlin M; Collins F; Tofts L; Avolio AP; Pacey V
    Am J Med Genet A; 2022 Jun; 188(6):1761-1776. PubMed ID: 35224842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of Gastrointestinal Manifestations in Joint Hypermobility Syndromes.
    Botrus G; Baker O; Borrego E; Ngamdu KS; Teleb M; Gonzales Martinez JL; Maldonado G; Hussein AM; McCallum R
    Am J Med Sci; 2018 Jun; 355(6):573-580. PubMed ID: 29891041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between mast cell activation syndrome, postural tachycardia syndrome, and Ehlers-Danlos syndrome.
    Wang E; Ganti T; Vaou E; Hohler A
    Allergy Asthma Proc; 2021 May; 42(3):243-246. PubMed ID: 33980338
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence and Predictors of Gastrointestinal Dysmotility in Patients with Hypermobile Ehlers-Danlos Syndrome: A Tertiary Care Center Experience.
    Alomari M; Hitawala A; Chadalavada P; Covut F; Al Momani L; Khazaaleh S; Gosai F; Al Ashi S; Abushahin A; Schneider A
    Cureus; 2020 Apr; 12(4):e7881. PubMed ID: 32489735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of gastrointestinal function and its' effect on bone mineral density and body composition in hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome.
    DiFrancisco-Donoghue J; Southard V; Margulies M; Jung MK; Allera A; Riley B
    J Clin Densitom; 2022; 25(4):536-543. PubMed ID: 35945116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?
    Aubry-Rozier B; Schwitzguebel A; Valerio F; Tanniger J; Paquier C; Berna C; Hügle T; Benaim C
    Rheumatol Int; 2021 Oct; 41(10):1785-1794. PubMed ID: 34398260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome.
    Lam CY; Palsson OS; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):277-287.e3. PubMed ID: 32109633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new insight on postural tachycardia syndrome in 102 adults with hypermobile Ehlers-Danlos Syndrome/hypermobility spectrum disorder.
    Celletti C; Borsellino B; Castori M; Censi F; Calcagnini G; Camerota F; Strano S
    Monaldi Arch Chest Dis; 2020 May; 90(2):. PubMed ID: 32434316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder.
    Brock I; Prendergast W; Maitland A
    Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):473-481. PubMed ID: 34747107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Assessment of Nutrition and Dietary Influences in Hypermobile Ehlers-Danlos Syndrome-A Cross-Sectional Study.
    Topan R; Pandya S; Williams S; Ruffle JK; Zarate-Lopez N; Aziz Q; Fikree A
    Am J Gastroenterol; 2024 Apr; 119(4):727-738. PubMed ID: 37970870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey.
    Teran-Wodzinski P; Kumar A
    Rheumatol Int; 2023 Oct; 43(10):1935-1945. PubMed ID: 37378685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center.
    Ritelli M; Chiarelli N; Cinquina V; Vezzoli M; Venturini M; Colombi M
    Am J Med Genet A; 2024 Feb; 194(2):174-194. PubMed ID: 37774134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.
    Thwaites PA; Gibson PR; Burgell RE
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1693-1709. PubMed ID: 35750466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.